Vivosim Labs Inc (VIVS) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access VIVS Annual Cash Flow →
Cash flow data covering Vivosim Labs Inc–Jun 30 2025 offers a view into how Jun 30 2026's cash position has developed alongside business activity.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2026)
3 Months
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Operating Activities
Income-1.34
Depreciation & amortization0.04
Amortization of Other Assets0.00
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Restructuring & Impairment Charges0.00
Provision For Loan Losses Expensed0.00
Inventories Decrease /-Increase0.00
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Business0.00
Share-based Compensation0.09
Income (Loss) from Equity Method Investments0.00
Financial Instruments and Foreign Currency Transaction0.00
Interest Accrued On Convertible Notes Payable-
Fair Value Of Warrant Liabilities In Excess Of Proceeds-
Loss On Inducement To Exercise-
Increase Decrease In Grants Receivable-
Amortization Of Deferred Financing Costs-
Increase Decrease In Deferred Rent-
Increase Decrease In Contract With Customer Liability-
Equity Securities Fv Ni Gain Loss-
Accretion On Investments-
Operating Lease Right Of Use Asset Amortization Expense0.34
Liability To Be Settled In The Equity-
Increase Decrease In Operating Lease Right Of Use Assets And Liabilities Net-0.37
Income taxes0.00
Losses/ -gains on Investments net0.00
Increase (Decrease) in Accounts Receivable0.00
Increase (Decrease) in Accounts Payable-0.40
Increase (Decrease) in Accrued Liabilities-0.24
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets-0.05
Other Working Capital0.00
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities-1.31
Discontinued operations0.00
Net Cash flow from Operating Activities-3.21
Investing Activities
Capital Expenditures-0.02
Sale of Capital Items0.00
Short-term Investments Proceeds0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Increase Decrease In Cash Deposits Released From Restriction-
Payments To Acquire Equity Securities Fv Ni-
Payments To Acquire Investment-
Proceeds From Maturities Prepayments And Calls Of Investments-
Liquidation Of Equity Securities-
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-0.02
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.00
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net-0.12
Proceeds From Issuance Of Common Stock And Warrants-
Repayment Of Convertible Notes And Interest Payable-
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations11.46
Repayment Of Insurance Premium Financing Liability-0.25
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities-0.12
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-3.24
Total Cash Flow-3.35
4 historic quarters locked

Sign in to unlock the full Vivosim Labs Inc cash flow history.

About Vivosim Labs Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001193125-26-346820

Figures are derived from filed reports and may be restated. Historical data is subject to revision.